All lobbying filings
Holland & Knight LLP
Holland & Knight LLP filed a Q3 report for Convatec, Inc. F/K/A Triad Life Sciences, Inc. on October 7, 2026, reporting $30,000 in lobbying income.
Lobbying for Convatec, Inc. F/K/A Triad Life Sciences, Inc. · Biotechnology
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 7, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
Tennessee
Government bodies contacted
3
Lobbying activity
1
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.